Early effects of different brain radiotherapy modalities on circulating leucocyte subpopulations in rodents

References

• Ahmed MM, Hodge JW, Guha C, Bernhard EJ, Vikram B, Coleman CN. 2013. Harnessing the potential of radiation-induced immune modulation for cancer therapy. Cancer Immunol Res. 1(5):280–284. doi:10.1158/2326-6066.CIR-13-0141
   PubMed Web of Science ®Google Scholar
• Bilen MA, Martini DJ, Liu Y, Lewis C, Collins HH, Shabto JM, Akce M, Kissick HT, Carthon BC, Shaib WL, et al. 2019. The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy: Inflammatory Biomarkers in Immunotherapy. Cancer. 125(1):127–134. doi:10.1002/cncr.31778
   PubMed Web of Science ®Google Scholar
• Blum KS, Pabst R. 2007. Lymphocyte numbers and subsets in the human blood. Immunol Lett. 108(1):45–51. doi:10.1016/j.imlet.2006.10.009
   PubMed Web of Science ®Google Scholar
• Buescher ES, Gallin JI. 1984. Radiation effects on cultured human monocytes and on monocyte-derived macrophages. Blood. 63(6):1402–1407. doi:10.1182/blood.V63.6.1402.1402
   PubMed Web of Science ®Google Scholar
• Chen F, Jin J-Y, Hui TSK, Jing H, Zhang H, Nong Y, Han Y, Wang W, Ma L, Yi F, et al. 2022. Radiation induced lymphopenia is associated with the effective dose to the circulating immune cells in breast cancer. Front Oncol. 12:768956. doi:10.3389/fonc.2022.768956
   PubMed Web of Science ®Google Scholar
• Cho Y, Kim J, Yoon H, Lee C, Keum K, Lee I. 2018. The prognostic significance of neutrophil-to-lymphocyte ratio in head and neck cancer patients treated with radiotherapy. J Clin Med. 7(12):512. doi:10.3390/jcm7120512
   PubMed Web of Science ®Google Scholar
• Coupey J, Pham TN, Toutain J, Ivanova V, Hue E, Helaine C, Ismail A, Saulnier R, Simonin G, Rousseau M, et al. 2024. Investigating the effects of protons versus x-rays on radiation-induced lymphopenia after brain irradiation. bioRxiv. https://doi.org/10.1101/2024.03.02.583088
   Google Scholar
• de Andrade Carvalho H, Villar RC. 2018. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo). 73(suppl 1):e557s. doi:10.6061/clinics/2018/e557s
   PubMedGoogle Scholar
• Ellsworth SG. 2018. Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors. Adv Radiat Oncol. 3(4):512–519. doi:10.1016/j.adro.2018.08.014
   PubMedGoogle Scholar
• Ellsworth SG, Yalamanchali A, Lautenschlaeger T, Grossman SA, Grassberger C, Lin SH, Mohan R. 2022. Lymphocyte depletion rate as a biomarker of radiation dose to circulating lymphocytes during fractionated partial-body radiation therapy. Adv Radiat Oncol. 7(5):100959. doi:10.1016/j.adro.2022.100959
   PubMedGoogle Scholar
• Fadul CE, Fisher JL, Gui J, Hampton TH, Côté AL, Ernstoff MS. 2011. Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme. Neuro Oncol. 13(4):393–400. doi:10.1093/neuonc/noq204
   PubMed Web of Science ®Google Scholar
• Farese AM, Hankey KG, Cohen MV, MacVittie TJ. 2015. Lymphoid and myeloid recovery in rhesus macaques following total body X-irradiation. Health Phys. 109(5):414–426. doi:10.1097/hp.0000000000000348
   PubMed Web of Science ®Google Scholar
• Gaikwad U, Bajpai J, Jalali R. 2023. Combinatorial approach of immuno‐proton therapy in cancer: rationale and potential impact. Asia Pac J Clin Oncol. Early View. doi:10.1111/ajco.13966
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Aryankalayil MJ, Coleman CN, Formenti SC. 2023. Emerging evidence for adapting radiotherapy to immunotherapy. Nat Rev Clin Oncol. 20(8):543–557. doi:10.1038/s41571-023-00782-x
   PubMed Web of Science ®Google Scholar
• Ghanavati S. 2017. Quantitative Analysis and Comparison of Cerebrovasculature in Common Mouse Strains: C57BL/6, CD-1, CBA, and 129/Sv using Imaging, Automatic Segmentation and Labelling of the Cerebral Vessels. Graduate Department of Medical Biophysics, University of Toronto.
   Google Scholar
• Hall C, Lueshen E, Mošat’ A, Linninger AA. 2012. Interspecies scaling in pharmacokinetics: a novel whole-body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo. J Pharm Sci. 101(3):1221–1241. doi:10.1002/jps.22811
   PubMed Web of Science ®Google Scholar
• Hammi A, Paganetti H, Grassberger C. 2020. 4D blood flow model for dose calculation to circulating blood and lymphocytes. Phys Med Biol. 65(5):055008. doi:10.1088/1361-6560/ab6c41
   PubMed Web of Science ®Google Scholar
• He H, Geng T, Chen P, Wang M, Hu J, Kang L, Song W, Tang H. 2016. NK cells promote neutrophil recruitment in the brain during sepsis-induced neuroinflammation. Sci Rep. 6(1):27711. doi:10.1038/srep27711
   PubMedGoogle Scholar
• Holley TR, Van Epps DE, Harvey RL, Anderson RE, Williams RC. 1974. Effect of high doses of radiation on human neutrophil chemotaxis, phagocytosis and morphology. Am J Pathol. 75(1):61–72.
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Littlefield LG. 1968. Chromosome damage induced by plasma of X-rayed patients: an indirect effect of X-ray. Proc Soc Exp Biol Med. 129(1):240–244. doi:10.3181/00379727-129-33295
   PubMed Web of Science ®Google Scholar
• Holub K, Vargas A, Biete A. 2020. Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients. Clin Transl Oncol. 22(11):2040–2048. doi:10.1007/s12094-020-02345-3
   PubMed Web of Science ®Google Scholar
• Huang J, DeWees TA, Badiyan SN, Speirs CK, Mullen DF, Fergus S, Tran DD, Linette G, Campian JL, Chicoine MR, et al. 2015. Clinical and dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent temozolomide for high-grade glioma. Int J Radiat Oncol Biol Phys. 92(5):1000–1007. doi:10.1016/j.ijrobp.2015.04.005
   PubMed Web of Science ®Google Scholar
• Jin J-Y, Gu A, Wang W, Oleinick NL, Machtay M, (Spring) Kong F-M. 2020. Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect? Radiother Oncol. 149:55–62. doi:10.1016/j.radonc.2020.04.054
   PubMed Web of Science ®Google Scholar
• Kapoor V, Khudanyan A, de la Puente P, Campian J, Hallahan DE, Azab AK, Thotala D. 2015. Stem cell transfusion restores immune function in radiation-induced lymphopenic C57BL/6 mice. Cancer Res. 75(17):3442–3445. doi:10.1158/0008-5472.CAN-15-1412
   PubMed Web of Science ®Google Scholar
• Ladbury CJ, Rusthoven CG, Camidge DR, Kavanagh BD, Nath SK. 2019. Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys. 105(2):346–355. doi:10.1016/j.ijrobp.2019.05.064
   PubMed Web of Science ®Google Scholar
• Leblond MM, Pérès EA, Helaine C, Gérault AN, Moulin D, Anfray C, Divoux D, Petit E, Bernaudin M, Valable S. 2017. M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma. Oncotarget. 8(42):72597–72612. doi:10.18632/oncotarget.19994
   PubMedGoogle Scholar
• Lesueur P, Calugaru V, Nauraye C, Stefan D, Cao K, Emery E, Reznik Y, Habrand JL, Tessonnier T, Chaikh A, et al. 2019. Proton therapy for treatment of intracranial benign tumors in adults: A systematic review. Cancer Treat Rev. 72:56–64. doi:10.1016/j.ctrv.2018.11.004
   PubMed Web of Science ®Google Scholar
• Macintyre AN, French MJ, Sanders BR, Riebe KJ, Shterev ID, Wiehe K, Hora B, Evangelous T, Dugan G, Bourland JD, et al. 2021. Long-term recovery of the adaptive immune system in rhesus macaques after total body irradiation. Adv Radiat Oncol. 6(5):100677. doi:10.1016/j.adro.2021.100677
   PubMedGoogle Scholar
• Ménétrier-Caux C, Ray-Coquard I, Blay J-Y, Caux C. 2019. Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines? J Immunotherapy Cancer. 7(1):85. doi:10.1186/s40425-019-0549-5
   PubMedGoogle Scholar
• Miszczyk J, Rawojć K, Panek A, Borkowska A, Prasanna PGS, Ahmed MM, Swakoń J, Gałaś A. 2018. Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms? Clin Transl Radiat Oncol. 9:23–29. doi:10.1016/j.ctro.2018.01.004
   PubMed Web of Science ®Google Scholar
• Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, et al. 2021. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons. Neuro Oncol. 23(2):284–294. doi:10.1093/neuonc/noaa182
   PubMed Web of Science ®Google Scholar
• Murshed H. 2019. Proton radiation therapy. In Fundamentals of radiation oncology. Elsevier; [accessed 2022 Dec 6]. p. 161–171. doi:10.1016/B978-0-12-814128-1.00009-X
   Google Scholar
• Nakamura N, Kusunoki Y, Akiyama M. 1990. Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay. Radiat Res. 123(2):224–227.
   PubMed Web of Science ®Google Scholar
• Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihöfer C, Schüttrumpf L, Ernst A, Niemöller OM, Belka C. 2014. Current concepts in clinical radiation oncology. Radiat Environ Biophys. 53(1):1–29. doi:10.1007/s00411-013-0497-2
   PubMed Web of Science ®Google Scholar
• Park H-R, Jung U. 2021. Depletion of NK cells resistant to ionizing radiation increases mutations in mice after whole-body irradiation. In Vivo. 35(3):1507–1513. doi:10.21873/invivo.12403
   PubMed Web of Science ®Google Scholar
• Pham T-N, Coupey J, Candeias SM, Ivanova V, Valable S, Thariat J. 2023. Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches. J Exp Clin Cancer Res. 42(1):50. doi:10.1186/s13046-023-02621-4
   PubMed Web of Science ®Google Scholar
• R Core Team. 2021. R: A Language and Environment for Statistical Computing [Internet]. https://www.R-project.org/.
   Google Scholar
• Shohan J. 1916. Some theoretical considerations on the present status of roentgen therapy. Boston Med Surg J. 175(10):321–327. doi:10.1056/NEJM191609071751001
   Google Scholar
• Tang C, Liao Z, Gomez D, Levy L, Zhuang Y, Gebremichael RA, Hong DS, Komaki R, Welsh JW. 2014. Lymphopenia association with gross tumor volume and lung v5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys. 89(5):1084–1091. doi:10.1016/j.ijrobp.2014.04.025
   PubMed Web of Science ®Google Scholar
• Thariat J, Hannoun-Levi J-M, Sun Myint A, Vuong T, Gérard J-P. 2013. Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol. 10(1):52–60. doi:10.1038/nrclinonc.2012.203
   PubMed Web of Science ®Google Scholar
• Therneau T, Atkinson B, Ripley B. 2022. rpart: Recursive partitioning and regression trees. https://CRAN.R-project.org/package=rpart
   Google Scholar
• Venkatesulu BP, Sharma A, Pollard-Larkin JM, Sadagopan R, Symons J, Neri S, Singh PK, Tailor R, Lin SH, Krishnan S. 2019. Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome. Sci Rep. 10(1):11018. doi:10.1038/s41598-019-53562-y
   Web of Science ®Google Scholar
• Widick P, Winer ES. 2016. Leukocytosis and leukemia. Prim Care. 43(4):575–587. doi:10.1016/j.pop.2016.07.007
   PubMed Web of Science ®Google Scholar
• Wu Q, Allouch A, Martins I, Brenner C, Modjtahedi N, Deutsch E, Perfettini J-L. 2017. Modulating both tumor cell death and innate immunity is essential for improving radiation therapy effectiveness. Front Immunol. 8:613. doi:10.3389/fimmu.2017.00613
   PubMed Web of Science ®Google Scholar
• Yovino S, Kleinberg L, Grossman SA, Narayanan M, Ford E. 2013. The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest. 31(2):140–144. doi:10.3109/07357907.2012.762780
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu X, Chen D, Yu J. 2022. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Sig Transduct Target Ther. 7(1):258. doi:10.1038/s41392-022-01102-y
   PubMed Web of Science ®Google Scholar